These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38134582)

  • 1. Validity and reliability of the MetabQoL 1.0 and assessment of neuropsychiatric burden in organic acidemias: Reflections from Turkey.
    Ersak AŞ; Çak HT; Yıldız Y; Çavdar MK; Tunç S; Özer N; Zeltner NA; Huemer M; Tokatlı A; Haliloğlu G
    Mol Genet Metab; 2024 Jan; 141(1):108117. PubMed ID: 38134582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of liver transplantation on health-related quality of life in (acute) intoxication-type inborn errors of metabolism.
    Greco B; Caviglia S; Martinelli D; Capitello TG; Liccardo D; De Nictolis F; Pietrobattista A; Huemer M; Piga S; Olivieri G; Spagnoletti G; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2023 Sep; 46(5):906-915. PubMed ID: 37395264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).
    Sikirica V; Schwartz EJ; Vockley J; Stagni K; Bellenger MA; Banerjee G; Durgam N; Moshkovich O
    Mol Genet Metab; 2024; 143(1-2):108577. PubMed ID: 39303317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Psychometric Evaluation of the MetabQoL 1.0: A Quality of Life Questionnaire for Paediatric Patients with Intoxication-Type Inborn Errors of Metabolism.
    Zeltner NA; Baumgartner MR; Bondarenko A; Ensenauer R; Karall D; Kölker S; Mühlhausen C; Scholl-Bürgi S; Thimm E; Quitmann J; Burgard P; Landolt MA; Huemer M
    JIMD Rep; 2017; 37():27-35. PubMed ID: 28247338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic acidemias in the neonatal period: 30 years of experience in a referral center for inborn errors of metabolism.
    Unsal Y; Yurdakok M; Yigit S; Celik HT; Dursun A; Sivri HS; Tokatli A; Coskun T
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1345-1356. PubMed ID: 36203204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
    Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
    J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report.
    Jiang YZ; Shi Y; Shi Y; Gan LX; Kong YY; Zhu ZJ; Wang HB; Sun LY
    Orphanet J Rare Dis; 2019 Dec; 14(1):292. PubMed ID: 31842933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias.
    Nizon M; Ottolenghi C; Valayannopoulos V; Arnoux JB; Barbier V; Habarou F; Desguerre I; Boddaert N; Bonnefont JP; Acquaviva C; Benoist JF; Rabier D; Touati G; de Lonlay P
    Orphanet J Rare Dis; 2013 Sep; 8():148. PubMed ID: 24059531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.
    Molema F; Jacobs EH; Onkenhout W; Schoonderwoerd GC; Langendonk JG; Williams M
    J Inherit Metab Dis; 2018 Nov; 41(6):1179-1187. PubMed ID: 30159853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.
    Kölker S; Valayannopoulos V; Burlina AB; Sykut-Cegielska J; Wijburg FA; Teles EL; Zeman J; Dionisi-Vici C; Barić I; Karall D; Arnoux JB; Avram P; Baumgartner MR; Blasco-Alonso J; Boy SP; Rasmussen MB; Burgard P; Chabrol B; Chakrapani A; Chapman K; Cortès I Saladelafont E; Couce ML; de Meirleir L; Dobbelaere D; Furlan F; Gleich F; González MJ; Gradowska W; Grünewald S; Honzik T; Hörster F; Ioannou H; Jalan A; Häberle J; Haege G; Langereis E; de Lonlay P; Martinelli D; Matsumoto S; Mühlhausen C; Murphy E; de Baulny HO; Ortez C; Pedrón CC; Pintos-Morell G; Pena-Quintana L; Ramadža DP; Rodrigues E; Scholl-Bürgi S; Sokal E; Summar ML; Thompson N; Vara R; Pinera IV; Walter JH; Williams M; Lund AM; Garcia-Cazorla A
    J Inherit Metab Dis; 2015 Nov; 38(6):1059-74. PubMed ID: 25875216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia.
    Maines E; Catesini G; Boenzi S; Mosca A; Candusso M; Dello Strologo L; Martinelli D; Maiorana A; Liguori A; Olivieri G; Taurisano R; Piemonte F; Rizzo C; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2020 Nov; 43(6):1173-1185. PubMed ID: 32681732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes.
    Critelli K; McKiernan P; Vockley J; Mazariegos G; Squires RH; Soltys K; Squires JE
    Liver Transpl; 2018 Sep; 24(9):1260-1270. PubMed ID: 30080956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for drug development in propionic and methylmalonic acidemias.
    Longo N; Sass JO; Jurecka A; Vockley J
    J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential interferents of methylmalonic acid: A previously unrecognized pitfall in clinical diagnostics and newborn screening.
    Monostori P; Godejohann M; Janda J; Galla Z; Rácz G; Klinke G; Szatmári I; Zsidegh P; Kohlmüller D; Kölker S; Hoffmann GF; Gramer G; Okun JG
    Clin Biochem; 2023 Jan; 111():72-80. PubMed ID: 36202155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR Spectroscopy in Diagnosis and Monitoring of Methylmalonic and Propionic Acidemias.
    Deleanu C; Nicolescu A
    Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiometabolic risk factor clustering in patients with deficient branched-chain amino acid catabolism: A case-control study.
    Gancheva S; Caspari D; Bierwagen A; Jelenik T; Caprio S; Santoro N; Rothe M; Markgraf DF; Herebian D; Hwang JH; Öner-Sieben S; Mennenga J; Pacini G; Thimm E; Schlune A; Meissner T; Vom Dahl S; Klee D; Mayatepek E; Roden M; Ensenauer R
    J Inherit Metab Dis; 2020 Sep; 43(5):981-993. PubMed ID: 32118306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
    Baumgartner MR; Hörster F; Dionisi-Vici C; Haliloglu G; Karall D; Chapman KA; Huemer M; Hochuli M; Assoun M; Ballhausen D; Burlina A; Fowler B; Grünert SC; Grünewald S; Honzik T; Merinero B; Pérez-Cerdá C; Scholl-Bürgi S; Skovby F; Wijburg F; MacDonald A; Martinelli D; Sass JO; Valayannopoulos V; Chakrapani A
    Orphanet J Rare Dis; 2014 Sep; 9():130. PubMed ID: 25205257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver burden, and parents' perception of disease severity determine health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism.
    Bösch F; Landolt MA; Baumgartner MR; Fernandez S; Forny P; Gautschi M; Grünert SC; Häberle J; Horvath C; Karall D; Lampis D; Rohrbach M; Scholl-Bürgi S; Szinnai G; Huemer M
    Mol Genet Metab Rep; 2022 Jun; 31():100876. PubMed ID: 35762020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.